AbCellera Biologics (ABCL)
(Delayed Data from NSDQ)
$2.61 USD
+0.10 (3.98%)
Updated Aug 23, 2024 04:00 PM ET
After-Market: $2.62 +0.01 (0.38%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth A Momentum F VGM
Brokerage Reports
AbCellera Biologics Inc. [ABCL]
Reports for Purchase
Showing records 1 - 20 ( 21 total )
Company: AbCellera Biologics Inc.
Industry: Medical - Biomedical and Genetics
Soft 2Q-2024 Results Reflect Focus shift. Invetx Monetization a sign of Percolating Value.
Provider: Bloom Burton & Company
Analyst: MARTIN D
Company: AbCellera Biologics Inc.
Industry: Medical - Biomedical and Genetics
Company: AbCellera Biologics Inc.
Industry: Medical - Biomedical and Genetics
Company: AbCellera Biologics Inc.
Industry: Medical - Biomedical and Genetics
Company: AbCellera Biologics Inc.
Industry: Medical - Biomedical and Genetics
Company: AbCellera Biologics Inc.
Industry: Medical - Biomedical and Genetics
Company: AbCellera Biologics Inc.
Industry: Medical - Biomedical and Genetics
Company: AbCellera Biologics Inc.
Industry: Medical - Biomedical and Genetics
Digital Biology Tech- Enabled Drug Discovery Initiation
Provider: KeyBanc Capital Markets
Analyst: Research Department
Company: AbCellera Biologics Inc.
Industry: Medical - Biomedical and Genetics
Company: AbCellera Biologics Inc.
Industry: Medical - Biomedical and Genetics
2Q-2023 Results : Slower pace of pertne, but long term Trajectory Remains on Track
Provider: Bloom Burton & Company
Analyst: BOROVINA A
Company: AbCellera Biologics Inc.
Industry: Medical - Biomedical and Genetics
Company: AbCellera Biologics Inc.
Industry: Medical - Biomedical and Genetics
Company: AbCellera Biologics Inc.
Industry: Medical - Biomedical and Genetics
1Q-2023 Revenues and Partnerships Light: Progress on Partnered Programs shows Platform potential
Provider: Bloom Burton & Company
Analyst: BOROVINA A
Company: AbCellera Biologics Inc.
Industry: Medical - Biomedical and Genetics
4Q-2022 Results-Light on Revenue, But Pipeline Momentum Builds.
Provider: Bloom Burton & Company
Analyst: BOROVINA A
Company: AbCellera Biologics Inc.
Industry: Medical - Biomedical and Genetics
Company: AbCellera Biologics Inc.
Industry: Medical - Biomedical and Genetics
Company: AbCellera Biologics Inc.
Industry: Medical - Biomedical and Genetics
Company: AbCellera Biologics Inc.
Industry: Medical - Biomedical and Genetics
Company: AbCellera Biologics Inc.
Industry: Medical - Biomedical and Genetics
Company: AbCellera Biologics Inc.
Industry: Medical - Biomedical and Genetics
FY-2021 Results Shifting focus to Program starts but Strategy Unchanged.
Provider: Bloom Burton & Company
Analyst: BOROVINA A